Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (51-60 of 395) with videos related to

Pageof 40
Sort By:
Minerva Anestesiologica|February 5, 2020
Acute reduction of cerebrospinal fluid volume prior to spinal anesthesia: implications for sensory block extentMartin F Bjurström, Niklas Mattsson, Andreas Harsten, et al.
Journal of Parkinson'S Disease|November 22, 2021
Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical SubtypesEmil Ygland Rödström, Niklas Mattsson-Carlgren, Shorena Janelidze, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 15, 2025
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's diseaseLyduine E Collij, Niklas Mattsson-Carlgren, Shorena Janelidze, et al.
JAMA Neurology|February 26, 2014
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality RegistryTobias Skillbäck, Christoffer Rosén, Fredrik Asztely, et al.
Plos One|August 11, 2012
Peptidome analysis of cerebrospinal fluid by LC-MALDI MSMikko Hölttä, Henrik Zetterberg, Ekaterina Mirgorodskaya, et al.
Practical Neurology|March 15, 2013
Coagulation of cerebrospinal fluid--the Nonne-Froin signNiklas Mattsson, Richard Montelius, Anders Holtz, et al.
Neurobiology of Aging|January 22, 2018
Amyloid pathology in the progression to mild cognitive impairmentPhilip S Insel, Oskar Hansson, R Scott Mackin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2016
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's diseaseNiklas Mattsson, Jonathan M Schott, John Hardy, et al.
Journal of Neuroinflammation|October 1, 2017
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort studyAndreas Pikwer, Markus Castegren, Sijal Namdar, et al.
Neurology|May 31, 2022
β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer DiseaseAtul Kumar, Shorena Janelidze, Erik Stomrud, et al.
Pageof 40

Showing results (51-60 of 395) with videos related to

Sort By:
Pageof 40
Minerva Anestesiologica|February 5, 2020
Acute reduction of cerebrospinal fluid volume prior to spinal anesthesia: implications for sensory block extentMartin F Bjurström, Niklas Mattsson, Andreas Harsten, et al.
Journal of Parkinson'S Disease|November 22, 2021
Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical SubtypesEmil Ygland Rödström, Niklas Mattsson-Carlgren, Shorena Janelidze, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 15, 2025
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's diseaseLyduine E Collij, Niklas Mattsson-Carlgren, Shorena Janelidze, et al.
JAMA Neurology|February 26, 2014
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality RegistryTobias Skillbäck, Christoffer Rosén, Fredrik Asztely, et al.
Plos One|August 11, 2012
Peptidome analysis of cerebrospinal fluid by LC-MALDI MSMikko Hölttä, Henrik Zetterberg, Ekaterina Mirgorodskaya, et al.
Practical Neurology|March 15, 2013
Coagulation of cerebrospinal fluid--the Nonne-Froin signNiklas Mattsson, Richard Montelius, Anders Holtz, et al.
Neurobiology of Aging|January 22, 2018
Amyloid pathology in the progression to mild cognitive impairmentPhilip S Insel, Oskar Hansson, R Scott Mackin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2016
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's diseaseNiklas Mattsson, Jonathan M Schott, John Hardy, et al.
Journal of Neuroinflammation|October 1, 2017
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort studyAndreas Pikwer, Markus Castegren, Sijal Namdar, et al.
Neurology|May 31, 2022
β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer DiseaseAtul Kumar, Shorena Janelidze, Erik Stomrud, et al.
Pageof 40